Prospective oral mucositis audit : oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy : european blood and marrow transplantation mucositis advisory group
Date Issued
2008-01-01
Author(s)
Blijlevens, Nicole
Bacon, Pamela
D'Addio, Alessandra
Einsele, Hermann
Maertens, Johan
Niederwieser, Dietger
Rabitsch, Werner
Roosaar, Ann
Ruutu, Tapani
Schouten, Harry
Stone, Rebecca
Vokurka, Samuel
Quinn, Barry
McCann, Shaun
DOI
10.1200/jco.2007.13.6028
Abstract
The Prospective Oral Mucositis Audit assessed the incidence, duration, and determinants of severe oral mucositis (OM; WHO oral toxicity scale grades 3 to 4) in patients with multiple myeloma (MM) or non-Hodgkin's lymphoma (NHL) receiving high-dose conditioning chemotherapy before autologous stem-cell transplantation.